Mindset Pharma Stock Revenue
MSSTFDelisted Stock | USD 0.36 0.00 0.00% |
Mindset Pharma fundamentals help investors to digest information that contributes to Mindset Pharma's financial success or failures. It also enables traders to predict the movement of Mindset OTC Stock. The fundamental analysis module provides a way to measure Mindset Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mindset Pharma otc stock.
Mindset |
Mindset Pharma OTC Stock Revenue Analysis
Mindset Pharma's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Mindset Pharma Revenue | 3.91 M |
Most of Mindset Pharma's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mindset Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Mindset Pharma reported 3.91 M of revenue. This is 99.95% lower than that of the Healthcare sector and 99.47% lower than that of the Biotechnology industry. The revenue for all United States stocks is 99.96% higher than that of the company.
Mindset Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mindset Pharma's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mindset Pharma could also be used in its relative valuation, which is a method of valuing Mindset Pharma by comparing valuation metrics of similar companies.Mindset Pharma is currently under evaluation in revenue category among its peers.
Mindset Fundamentals
Return On Equity | -2.43 | |||
Return On Asset | -0.48 | |||
Profit Margin | (1.64) % | |||
Operating Margin | (1.33) % | |||
Current Valuation | 19.22 M | |||
Shares Outstanding | 95.25 M | |||
Shares Owned By Insiders | 9.00 % | |||
Shares Owned By Institutions | 0.88 % | |||
Price To Book | 28.87 X | |||
Price To Sales | 4.83 X | |||
Revenue | 3.91 M | |||
Gross Profit | 3.91 M | |||
EBITDA | (16.53 M) | |||
Net Income | (16.61 M) | |||
Cash And Equivalents | 8.71 M | |||
Cash Per Share | 0.09 X | |||
Total Debt | 171.79 K | |||
Debt To Equity | 0.12 % | |||
Current Ratio | 1.18 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | 385.56 K | |||
Earnings Per Share | (0.19) X | |||
Target Price | 5.02 | |||
Beta | -0.28 | |||
Market Capitalization | 20.95 M | |||
Total Asset | 9.77 M | |||
Z Score | 69.3 | |||
Net Asset | 9.77 M |
About Mindset Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mindset Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mindset Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mindset Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |